Search Results < Yale Cancer Center

2237 results

News
Rozalyn Levine Rodwin, MD, Awarded $100,000 Grant to Treat Survivors of Childhood Cancer
Rozalyn Levine Rodwin, MD, accepts an honorific $100,000 check from the Hyundai Hope on Wheels program.
17 Aug 2023
News
Women’s Health Research at Yale Funds Studies to Improve Early Detection of Ovarian Cancer, Treatment of Prenatal Infections, and Aortic Aneurysm Outcomes in Women
Women's Health Research at Yale announces recipients of 2023 Pilot Project Program Grants
16 May 2023
News
Sticky Nanoparticles Fight Skin Cancer
Using bioadhesive nanoparticles from the laboratory of Dr. W. Mark Saltzman, Dr. Michael Girardi and his team collaborated with Dr. Saltzman and loaded them with a one-two punch of chemotherapy plus immunotherapy to study its impact in skin cancer. The results may have significant impact for how skin cancer tumors are treated.
30 Mar 2022
News
Vida’s Story: Immunotherapy for Advanced Endometrial Cancer a Lifesaver at Smilow Cancer Hospital
Vida Chernoff lives life to the fullest after immunotherapy at Smilow Cancer Hospital
10 Aug 2021
News
Colorectal Cancer and Women
Colon cancer has been undergoing a similar subdivision. Researchers have known for years that colorectal cancer is the third most common cancer diagnosis in the United States and the second leading cause of cancer-related deaths. The National Cancer Institute estimates 149,500 new cases in 2021 and 53,000 deaths.
21 Jul 2021
News
Scientists Unravel Mystery of Sex Disparities in COVID-19 Outcomes
"Age and sex are where immunological changes intersect,” says Akiko Iwasaki, PhD. Over the past year, Iwasaki and her colleagues from around the globe have compiled a rich literature of research that reveals in detail these and other factors that make the virus more lethal for men.
Source: YaleNews
24 Jan 2021
News
Understanding Immune System Blunders in Response to the Coronavirus
Genetics, gender, and even botched timing on the part of the immune response all appear important in the development of COVID-19. Akiko Iwasaki, PhD, is leading research to help us better predict who is likely to sail through a bout with COVID-19 and who may need targeted lifesaving care.
19 Jan 2021
News
Treatment with Genetically Altered Viruses Targets and Destroys Ovarian Cancer in Mice
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.
12 Nov 2020
News
‘Every Minute Counts.’ This Immunologist Rapidly Reshaped Her Lab to Tackle COVID-19
“Having to adapt to different situations throughout my life prepared me [for] a different virus,” says Akiko Iwasaki of Yale University.
Source: Science
29 Oct 2020
News
WHRY Funds Study on Sex Differences in the Immune Response to the Coronavirus
Women’s Health Research at Yale announced funding for a unique study focusing on sex differences in immune responses to SARS-CoV-2, the virus which causes COVID-19.
23 Apr 2020
News
Yale Cancer Center research highlighted at ASTRO 2019
Yale Cancer Center (YCC) scientists presented research at the 61st annual American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
17 Sep 2019
News
Yale Cancer Center Researchers Show Adding Radiation After Immunotherapy Improves Survival Time for Patients with Advanced Lung Cancer
The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
16 Sep 2019
News
Yale Cancer Center Researchers Find Aid to Help Treat Different Cancers
Yale Cancer Center (YCC) scientists have uncovered the workings of a metabolic pathway or “gauge” that lets cancer cells detect when they have enough nutrients around them to grow.
10 Sep 2019
News
'Game-changing' immunotherapy cancer drug boosts survival rates five-fold
A new immunotherapy cancer drug boosts survival rate five-fold, scientists from Yale have found.
Source: The Telegraph
10 Sep 2019
News
Bristol-Myers Squibb's Opdivo Shows 5-Year Survival Benefit in Lung Cancer
Bristol-Myers Squibb released the pooled efficacy and safety results from its Phase III CheckMate -017 and CheckMate -057 trials in patients with previously treated advanced non-small cell lung cancer (NSCLC).
Source: BioSpace
10 Sep 2019
News
Yale Cancer Center Announces Key Leadership Appointments
Yale Cancer Center (YCC) is proud to announce several leadership appointments, including two new senior positions to help bolster YCC’s research mission in the coming years.
30 Aug 2019
News
Yale Cancer Center finding offers hope for treatment of incurable Childhood Brain cancer
A team of investigators at Yale Cancer Center (YCC) have found a major chink in the armor of an incurable childhood brain cancer called Diffuse Intrinsic Pontine Gliomas (DIPG).
22 Aug 2019
News
Genome screen uncovers new targets for cancer immunotherapy
A new genome-wide screen of 20,000 human genes in T cells have turned up several new candidates to unleash the immune system’s ability to attack a variety of tumor types, Yale Cancer Center researchers report Aug. 22 in the journal Cell.
22 Aug 2019
News
Yale's Review of Advances in Oncology - Highlights from the ASCO Annual Meeting 2019
Yale's review of the ASCO 2019 Annual Meeting was held in Westbrook, CT on June 14.
25 Jul 2019
News
Yale Cancer Center Partners in Fight to Help Eliminate HPV-related Cancers
Yale Cancer Center joins the Association of American Cancer Institutes (AACI) and its partner organizations to endorse a Call to Action for our nation to work together toward the elimination of human papillomavirus (HPV)-related cancers.
27 Jun 2019